TrialJournal of translational medicine2010

Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients.

Chor Sang ChimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.